Correlation Engine 2.0
Clear Search sequence regions


  • contrast media (2)
  • humans (1)
  • patients (4)
  • prognostic (1)
  • prostate (18)
  • Sizes of these terms reflect their relevance to your search.

    To prospectively evaluate the feasibility and reproducibility of the semiquantitative measurement of the unenhanced area of the prostate by trans-abdominal contrast-enhanced ultrasound (CEUS) performed immediately after prostate artery embolization (PAE) as a prognostic factor of success. Thirty-nine patients with PAE were prospectively included. They all underwent pre- and post-PAE trans-abdominal prostate CEUS. Two readers independently evaluated the pre- and post-PAE unenhanced area using a semiquantitative method: unenhanced areas were measured on 3 different slices (basis, middle, and apex) and reported to the whole prostate area. The mean of the three measures was reported semiquantitatively in classes of ten percent and quartiles. We evaluated correlation with clinical success, at 3 months after PAE, defined as a > 25% reduction in the International Prostatic Symptoms Score and a Quality of life < 3. Twenty-three patients who had bilateral PAE were analyzed. Pre-PAE trans-abdominal prostate CEUS showed visible early and marked enhancement of the entire prostate in all patients. After PAE, all patients had a semiquantitatively measured unenhanced area > 25%. The semiquantitative measurement was found to be highly reproducible, with an interclass correlation > 0.8. No correlation was found between the area of unenhanced tissue and clinical success evaluated at 3 months. Trans-abdominal prostate CEUS performed early after PAE provides reproducible results and is a valuable tool to evaluate unenhanced areas of the prostate. 3, local non random sample.

    Citation

    Maxime Barat, Tom Boeken, Nadia Moussa, Alessandro Di Gaeta, Carole Déan, Nicolas Thioun, C Del Giudice, Olivier Pellerin, Marc Sapoval. Contrast-Enhanced Ultrasonography for the Early Evaluation of Prostate Artery Embolization. Cardiovascular and interventional radiology. 2020 Oct;43(10):1498-1504

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32435835

    View Full Text